Surging global prevalence of cervical cancer, expanding national screening guidelines incorporating primary high-risk HPV (hrHPV) testing over traditional Pap smears, and continuous molecular diagnostics innovations in real-time PCR and multiplex assays are driving rapid growth across the Hpv Test Reagent Kit Market. HPV test reagent kits—comprising high-risk HPV DNA and mRNA detection...
